A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.
Saved in:
| Title: | A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial. |
|---|---|
| Authors: | Kane JM; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, 75-59 263rd St, Glen Oaks, NY, 11004, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA., Eshet R; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Harary E; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Tohami O; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Elgart A; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Knebel H; Global Patient Safety and Pharmacovigilance, Teva Pharmaceutical Industries Ltd. , Netanya, Israel., Sharon N; Innovative Medicines, Global Clinical Development, Teva Pharmaceutical Industries Ltd., Netanya, Israel., Suett M; Global Medical Affairs, Teva UK Limited, Harlow, UK., Franzenburg KR; Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Davis GL 3rd; Global Clinical Operations, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA., Correll CU; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, 75-59 263rd St, Glen Oaks, NY, 11004, USA. CCorrell@northwell.edu.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. CCorrell@northwell.edu.; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA. CCorrell@northwell.edu.; Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany. CCorrell@northwell.edu. |
| Source: | CNS drugs [CNS Drugs] 2024 Aug; Vol. 38 (8), pp. 625-636. Date of Electronic Publication: 2024 Jul 02. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1934 |
|---|---|
| DOI: | 10.1007/s40263-024-01102-2 |
